University of Minnesota heads federal COVID-19 antibody trial
![](https://www.hennepinhealthcare.org/wp-content/plugins/bb-plugin/img/pixel.png)
Locally, HCMC is participating in the first trial and enrolling patients, who must be admitted to hospitals for COVID-19 and be taking the antiviral drug remdesivir. A separate U.S. clinical trial group is studying the use of antibody therapies on an outpatient basis.